Structural Characterization of Pharmaceutical Heparins Prepared from Different Animal Tissues
- 1 May 2013
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 102 (5) , 1447-1457
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Top-Down Approach for the Direct Characterization of Low Molecular Weight Heparins Using LC-FT-MSAnalytical Chemistry, 2012
- Using an Enzymatic Combinatorial Approach to Identify Anticoagulant Heparan Sulfate StructuresChemistry & Biology, 2007
- Purification and Characterization of Heparin from the Italian ClamCallistachioneBiomacromolecules, 2005
- Determination of molecular weight of heparin by size exclusion chromatography with universal calibrationAnalytical Biochemistry, 2003
- NEW VARIANT CREUTZFELDT–JAKOB DISEASE AND BOVINE SPONGIFORM ENCEPHALOPATHYInfectious Disease Clinics of North America, 1998
- Isolation and characterization of human heparinBiochemistry, 1992
- Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sourcesBiochemistry, 1990
- Mapping and quantification of the major oligosaccharide components of heparinBiochemical Journal, 1988
- Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphatesBiochemical Journal, 1986
- Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin.Proceedings of the National Academy of Sciences, 1980